Weight
Why are millions of people with osteoporosis still undiagnosed? New report reveals all
An International Osteoporosis Foundation (IOF) report issued for World Osteoporosis Day has identified major care gaps and solutions to the global healthcare crisis arising from fragility fractures. Continue reading
The body suppresses inflammation in the night, says new study
A new study by researchers at the University of Manchester has shown how the body is able to suppress inflammation at night. This new discovery helps to explain how the body suppresses inflammation while we are asleep and how many people with arthritis wake up feeling stiff in the morning. Continue reading
Study suggests steroid treatments for rheumatoid arthritis could be safer in future
A new study, published in Science Translational Medicine, suggests steroid treatment for conditions such as rheumatoid arthritis could be made safer in future. These findings come following the discovery of a new therapeutic approach with a lower risk of side effects. Continue reading
Certolizumab pegol to treat patients with axial spondyloarthritis
A new study has reported that early rapid improvements in the signs and symptoms of axial spondyloarthritis in patients treated with certolizumab pegol have been maintained at four years.
A cohort of patients with radiographic axial spondyloarthritis (axSpA) and non-radiographic-axSpA who were randomised to take certolizumab pegol or placebo as part of the phase III RAPID-axSpA trial and the outcomes were examined at week 204. Continue reading
New arthritis jab offers hope to patients who fail to respond to treatments already available on the NHS
A new painkilling injection could be available for people with arthritis as early as next spring.
The new experimental drug, Sarilumab, is currently under review by the European Medicines Agency, which authorizes new drugs in Britain and the rest of the EU and if it is given the go ahead, it could be made available on the NHS to patients who have failed to respond to current available treatments, after it was shown to help almost two thirds of patients in a trial. Continue reading
